Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas

NCT06644287 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06644287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06644287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2024
Completion date
July 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced soft tissue sarcomas